Blueprint Medicines Statistics
Total Valuation
Marlowe has a market cap or net worth of 458.66 million. The enterprise value is 459.98 million.
| Market Cap | 458.66M |
| Enterprise Value | 459.98M |
Important Dates
The next estimated earnings date is Thursday, September 4, 2025.
| Earnings Date | Sep 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 78.52M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -7.70% |
| Shares Change (QoQ) | -10.46% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 50.21M |
Valuation Ratios
The trailing PE ratio is 2.52 and the forward PE ratio is 23.26.
| PE Ratio | 2.52 |
| Forward PE | 23.26 |
| PS Ratio | 1.17 |
| PB Ratio | 1.87 |
| P/TBV Ratio | 8.81 |
| P/FCF Ratio | 14.92 |
| P/OCF Ratio | 10.76 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.56, with an EV/FCF ratio of 14.96.
| EV / Earnings | 2.52 |
| EV / Sales | 1.14 |
| EV / EBITDA | 10.56 |
| EV / EBIT | 28.46 |
| EV / FCF | 14.96 |
Financial Position
The company has a current ratio of 1.42, with a Debt / Equity ratio of 0.12.
| Current Ratio | 1.42 |
| Quick Ratio | 1.22 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | 0.71 |
| Debt / FCF | 0.97 |
| Interest Coverage | 3.49 |
Financial Efficiency
Return on equity (ROE) is 1.40% and return on invested capital (ROIC) is 1.68%.
| Return on Equity (ROE) | 1.40% |
| Return on Assets (ROA) | 1.30% |
| Return on Invested Capital (ROIC) | 1.68% |
| Return on Capital Employed (ROCE) | 5.69% |
| Revenue Per Employee | 108,799 |
| Profits Per Employee | 50,415 |
| Employee Count | 3,616 |
| Asset Turnover | 0.52 |
| Inventory Turnover | 18.14 |
Taxes
| Income Tax | -2.07M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +10.24% in the last 52 weeks. The beta is 0.09, so Marlowe's price volatility has been lower than the market average.
| Beta (5Y) | 0.09 |
| 52-Week Price Change | +10.24% |
| 50-Day Moving Average | 5.79 |
| 200-Day Moving Average | 4.63 |
| Relative Strength Index (RSI) | 40.23 |
| Average Volume (20 Days) | 1,198 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Marlowe had revenue of 393.42 million and earned 182.30 million in profits. Earnings per share was 2.06.
| Revenue | 393.42M |
| Gross Profit | 160.21M |
| Operating Income | 15.76M |
| Pretax Income | 3.62M |
| Net Income | 182.30M |
| EBITDA | 29.97M |
| EBIT | 15.76M |
| Earnings Per Share (EPS) | 2.06 |
Balance Sheet
The company has 28.68 million in cash and 29.97 million in debt, giving a net cash position of -1.29 million.
| Cash & Cash Equivalents | 28.68M |
| Total Debt | 29.97M |
| Net Cash | -1.29M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 244.84M |
| Book Value Per Share | 3.04 |
| Working Capital | 39.41M |
Cash Flow
In the last 12 months, operating cash flow was 42.64 million and capital expenditures -11.89 million, giving a free cash flow of 30.75 million.
| Operating Cash Flow | 42.64M |
| Capital Expenditures | -11.89M |
| Free Cash Flow | 30.75M |
| FCF Per Share | n/a |
Margins
Gross margin is 40.72%, with operating and profit margins of 4.01% and 46.34%.
| Gross Margin | 40.72% |
| Operating Margin | 4.01% |
| Pretax Margin | 0.92% |
| Profit Margin | 46.34% |
| EBITDA Margin | 7.62% |
| EBIT Margin | 4.01% |
| FCF Margin | 7.82% |
Dividends & Yields
Marlowe does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 7.70% |
| Shareholder Yield | n/a |
| Earnings Yield | 39.75% |
| FCF Yield | 6.70% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Marlowe has an Altman Z-Score of 4.18 and a Piotroski F-Score of 6.
| Altman Z-Score | 4.18 |
| Piotroski F-Score | 6 |